Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hydroxymethylglutaryl-coa Reductase Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03018444
What this trial is testing

The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion

Who this might be right for
Diabetes Mellitus, Type 2Hydroxymethylglutaryl-CoA Reductase Inhibitors
University Hospital, Gentofte, Copenhagen 15
Large-scale testing (Phase 3)Study completedNCT00239330
What this trial is testing

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Who this might be right for
Hypercholesteremia
AstraZeneca 824
Not applicableStudy completedNCT02820870
What this trial is testing

Quality Improvement and Personalization for Statins

Who this might be right for
Cardiovascular Disease
VA Office of Research and Development 43
Early research (Phase 1)Study completedNCT01695954
What this trial is testing

Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz

Who this might be right for
HyperlipidemiaHIV
NYU Langone Health 34
Post-approval studies (Phase 4)UnknownNCT01871792
What this trial is testing

Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction

Who this might be right for
Contrast-induced Nephropathy
Gachon University Gil Medical Center 404
Testing effectiveness (Phase 2)Study completedNCT01218204
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

Who this might be right for
DyslipidaemiasDyslipidemias
GlaxoSmithKline 287
Post-approval studies (Phase 4)UnknownNCT01807078
What this trial is testing

Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 200
Testing effectiveness (Phase 2)Study completedNCT02603328
What this trial is testing

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

Who this might be right for
Cerebral Cavernous Malformation
University of Chicago 80
Not applicableStudy completedNCT06622304
What this trial is testing

Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels

Who this might be right for
HypertensionDyslipidemiasInflammatory Response+2 more
Guangzhou Institute of Respiratory Disease 250,736
Post-approval studies (Phase 4)Study completedNCT01285544
What this trial is testing

The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia

Who this might be right for
DyslipidemiaCardiovascular DiseaseHypercholesterolemia
Seoul National University Hospital 289
Not applicableStudy completedNCT03961763
What this trial is testing

Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins

Who this might be right for
Cardiovascular DiseasesHyperlipidemiasDyslipidemias
University of Chester 44
Not applicableStudy completedNCT04320719
What this trial is testing

Optimizing Statin Tratment in People Living With Diabetes

Who this might be right for
Diabetes
University Hospital, Montpellier 387
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Post-approval studies (Phase 4)Looking for participantsNCT03770312
What this trial is testing

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study

Who this might be right for
Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease
Yonsei University 724
Post-approval studies (Phase 4)UnknownNCT05613400
What this trial is testing

Statin and Bone Health

Who this might be right for
Diabetes Mellitus, Type 2
The University of Hong Kong 240
Post-approval studies (Phase 4)Study completedNCT02234492
What this trial is testing

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)Cardiovascular Disease (CVD)
Ottawa Heart Institute Research Corporation 35
Early research (Phase 1)Study completedNCT00627575
What this trial is testing

AED/Statin Interaction Study

Who this might be right for
Epilepsy
GlaxoSmithKline 119
Post-approval studies (Phase 4)Ended earlyNCT05331053
What this trial is testing

MicroRNA Activation of LOX-1 Mechanisms in Endometriosis

Who this might be right for
Endometriosis
Penn State University 6
Post-approval studies (Phase 4)Ended earlyNCT04507373
What this trial is testing

7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events

Who this might be right for
Muscle CrampAcheWeakness, Muscle+1 more
University of Texas Southwestern Medical Center 3
Not applicableLooking for participantsNCT05482386
What this trial is testing

STREAM Trial - Biomarker

Who this might be right for
Statin Treatment for Primary Prevention
Insel Gruppe AG, University Hospital Bern 500
Next Page